The CounterAct program provides funding for therapeutics that reduce the mortality and morbidity caused by exposure to chemical threat agents. Proposals should include a description of the drug, how it will be used on humans and how it would be administered during a chemical emergency event. Specific areas of research interest include, but are not limited to:
- Traditional chemical warfare agents such as sarin, VX and soman gases
- Toxic industrial chemicals such as cyanide, hydrogen sulfide and phosgene
- Toxic agricultural chemicals such as insecticides and rodenticides
- Research on people who are particularly vulnerable, such as the young and elderly (this point will be given special consideration)
Drugs that are only effective before chemical exposure or must be administered within a very short time after exposure (1-15 minutes) will be given low priority. Projects cannot exceed two years or $250,000 in direct costs per year. Letters of intent are due December 31, 2012. For more information, see the link below:
http://grants.nih.gov/grants/guide/pa-files/PAR-13-005.html